Position in NVS
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$41,972,907
+$1,549,300 QoQ
Shares Held
267,821
+1.2% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#66
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Derivatives in NVS
reported options exposure · as of Dec 31, 2023CallValue
$0
CallShares
0
PutValue
$550
PutShares
200
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HighTower Advisors, LLC holds $4,788,622,872 across 16 Drug Manufacturers - General names. NVS ranks #10 (0.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
9,892,767 | $2,512,466,034 | |
| 2 | LLY |
ELI LILLY & Co
|
436,561 | $523,624,403 | |
| 3 | ABBV |
AbbVie Inc.
|
1,967,343 | $495,062,192 | |
| 4 | MRK |
Merck & Co., Inc.
|
3,679,920 | $472,869,720 | |
| 5 | AMGN |
Amgen Inc
|
816,257 | $295,582,984 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,534,627 | $193,884,775 | |
| 7 | AZN |
Astrazeneca PLC
|
455,278 | $86,329,814 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,126,721 | $64,921,664 |
All Filings in NVS
Export CSV
27 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $41,972,907 | 267,821 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $40,423,607 | 264,639 | Shares | Sole | 2026-05-05 | |
| 2025-12-31 | $34,657,071 | 251,375 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $32,470,752 | 253,203 | Shares | Sole | 2025-11-07 | |
| 2025-06-30 | $29,364,286 | 242,660 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $26,514,514 | 237,841 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $22,902,200 | 235,353 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $33,454,717 | 290,860 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $31,495,978 | 295,848 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $28,656,552 | 296,253 | Shares | Sole | 2024-05-06 | |
| 2023-12-31 | $29,177,199 | 288,969 | Shares | Sole | 2024-02-12 | |
| 2023-12-31 | $550 | 200 | Put | Sole | 2024-02-12 | |
| 2023-09-30 | $28,785,636 | 282,600 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $26,555,980 | 263,165 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $23,188,508 | 252,049 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $22,356,946 | 246,439 | Shares | Sole | 2023-02-09 | |
| 2022-09-30 | $18,564,606 | 244,239 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $20,593,621 | 243,625 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $26,337,460 | 300,142 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $26,782,701 | 306,193 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $25,231,174 | 308,525 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $28,454,562 | 311,865 | Shares | Sole | 2021-08-06 | |
| 2021-03-31 | $25,569,717 | 299,131 | Shares | Sole | 2021-05-10 | |
| 2020-12-31 | $26,741,537 | 283,189 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $21,153,454 | 243,255 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $19,049,028 | 218,102 | Shares | Sole | 2020-08-10 | |
| 2020-03-31 | $18,090,601 | 219,413 | Shares | Sole | 2020-05-21 | |
| No filing history on record for this holder in this stock. | ||||||